US5608046A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Conjugated 4'-desmethyl nucleoside analog compounds
Assignee: Ionis Pharmaceuticals Inc
•
Filing: 1994-09-29
•
Granted: 1997-03-04
•
Expires: 2014-09-29
Abstract
Abstract Tetrahydrofuranyl compounds are provided that are functionalized to include pendant conjugate groups, and which are useful in diagnostic assays and as research reagents. Novel intermediates for the synthesis of the compounds are also provided.
Inventors
- 👤 Phillip D. Cook
- 👤 Kelly Teng
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 23:20
CPC Classifications
C; C07; C07H; C07H21/00; A; A61; A61K; A61K31/00; A61K31/70; A61K47/00; A61K47/50; A61K47/51; A61K47/56; A61K47/59; C07D; C07D405/00; C07D405/02; C07D405/04; C07D405/14; C07F; C07F7/00; C07F7/02; C07F7/08; C07F7/18; C07F7/1804; C07H19/00; C07H19/02; C07H19/04; C07H19/06; C07H19/10; C07H19/16
Claims Analysis
Total Claims: 34
Claim 1
Independent Claim
147 words
A compound having the structure: ##STR13## wherein: R L is a group of formula: R.sub.C --[Y].sub.e --Z-- wherein: Z is O, S or HN; Y is a bivalent linker; e is 0 or 1; R C is alkyl, alkenyl, alkynyl, a polyamine, a polyether, a polythioether, a steroid molecule, a reporter molecule, an aromatic lipophilic molecule, a non-aromatic lipophilic molecule, a reporter enzyme, a peptide, a protein, a water soluble vitamin, a lipid soluble vitamin, a carbohydrate, a terpene molecule, a phospholipid, an intercalator, a cell receptor binding molecule, a crosslinking agent, or a porphyrin; B x is a nucleobase; X is H, OH, O-alkyl, O-alkoxyalkyl, O-alkylamino, or F; Q is O, S, CH 2 , CHF or CF 2 ; and R D is H, hydroxyl, an activated phosphorous group, a nucleoside, an activated nucleotide, a nucleotide, an oligonucleotide, an oligonucleoside or a protected derivative thereof.
Claim 2
Dependent Claim
147 words
A compound having the structure: ##STR13## wherein: R L is a group of formula: R.sub.C --[Y].sub.e --Z-- wherein: Z is O, S or HN; Y is a bivalent linker; e is 0 or 1; R C is alkyl, alkenyl, alkynyl, a polyamine, a polyether, a polythioether, a steroid molecule, a reporter molecule, an aromatic lipophilic molecule, a non-aromatic lipophilic molecule, a reporter enzyme, a peptide, a protein, a water soluble vitamin, a lipid soluble vitamin, a carbohydrate, a terpene molecule, a phospholipid, an intercalator, a cell receptor binding molecule, a crosslinking agent, or a porphyrin; B x is a nucleobase; X is H, OH, O-alkyl, O-alkoxyalkyl, O-alkylamino, or F; Q is O, S, CH 2 , CHF or CF 2 ; and R D is H, hydroxyl, an activated phosphorous group, a nucleoside, an activated nucleotide, a nucleotide, an oligonucleotide, an oligonucleoside or a protected derivative thereof.
Claim 3
Dependent Claim
240 words
The compound having the structure: ##STR14## wherein: L is a group of formula: R 7 --[W] a --[S--(CH 2 ) q ] u --[HN--(CH 2 ) n ] t --.sub.[O--(CH 2 ) m ] v --Z-- wherein: t, u and v are each independently integers from 0 to 200; m, n and q are each independently integers from 1 to 4; Z is S, O or HN; R 7 is R c , H, or a protecting group; B x is a nucleobase; X is H, OH, O-alkyl, O-alkoxylalkyl, O-alkylamino, or F; Q is O; W is the residue of a linking moiety, said linking moiety being selected from the group consisting of acid chlorides, anhydrides, cyclic anhydrides, alkyl halides, organometallics, chloroformates, isocynates, hydrazines, acids, hydroxylamines, semicarbazides, thiosemicarbazides, hydrazones, hydrazides, trityl thiol, oximes, hydrazide-hydrazones, semicarbazones and semithiocarbazones; a is 0 or 1; R D is H, hydroxyl, an activated phosphorous group, a nucleoside, an activated nucleotide, a nucleotide, an oligonucleotide, an oligonucleoside or a protected derivative thereof; R C is alkyl, alkenyl, alkynyl, a polyamine, a polyether, a polythioether, a steroid molecule, a reporter molecule, an aromatic lipophilic molecule, a non-aromatic lipophilic molecule, a reporter enzyme, a peptide, a protein, a water soluble vitamin, a lipid soluble vitamin, a carbohydrate, a terpene molecule, a phospholipid, an intercalator, a cell receptor binding molecule, a crosslinking agent, or a porphyrin; and provided that t, u and v are not all simultaneously 0.
Claim 4
Dependent Claim
240 words
The compound having the structure: ##STR14## wherein: L is a group of formula: R 7 --[W] a --[S--(CH 2 ) q ] u --[HN--(CH 2 ) n ] t --.sub.[O--(CH 2 ) m ] v --Z-- wherein: t, u and v are each independently integers from 0 to 200; m, n and q are each independently integers from 1 to 4; Z is S, O or HN; R 7 is R c , H, or a protecting group; B x is a nucleobase; X is H, OH, O-alkyl, O-alkoxylalkyl, O-alkylamino, or F; Q is O; W is the residue of a linking moiety, said linking moiety being selected from the group consisting of acid chlorides, anhydrides, cyclic anhydrides, alkyl halides, organometallics, chloroformates, isocynates, hydrazines, acids, hydroxylamines, semicarbazides, thiosemicarbazides, hydrazones, hydrazides, trityl thiol, oximes, hydrazide-hydrazones, semicarbazones and semithiocarbazones; a is 0 or 1; R D is H, hydroxyl, an activated phosphorous group, a nucleoside, an activated nucleotide, a nucleotide, an oligonucleotide, an oligonucleoside or a protected derivative thereof; R C is alkyl, alkenyl, alkynyl, a polyamine, a polyether, a polythioether, a steroid molecule, a reporter molecule, an aromatic lipophilic molecule, a non-aromatic lipophilic molecule, a reporter enzyme, a peptide, a protein, a water soluble vitamin, a lipid soluble vitamin, a carbohydrate, a terpene molecule, a phospholipid, an intercalator, a cell receptor binding molecule, a crosslinking agent, or a porphyrin; and provided that t, u and v are not all simultaneously 0.
Claim 5
Dependent Claim
11 words
The compound of claim 2 wherein t and u are 0.
Claim 6
Dependent Claim
15 words
The compound of claim 2 wherein t and u are 0, and m is 2.
Claim 7
Dependent Claim
11 words
The compound of claim 2 wherein u and v are 0.
Claim 8
Dependent Claim
15 words
The compound of claim 2 wherein u and v are 0 and n is 2.
Claim 9
Dependent Claim
11 words
The compound of claim 2 wherein X is H or OH.
Claim 10
Dependent Claim
12 words
The compound of claim 2 wherein R D is H or OH.
Claim 11
Dependent Claim
13 words
The compound of claim 2 wherein R D is an activated phosphorous group.
Claim 12
Dependent Claim
11 words
A compound of claim 2 wherein R D is an oligonucleotide.
Claim 13
Dependent Claim
11 words
The compound of claim 2 wherein t and v are 0.
Claim 14
Dependent Claim
15 words
The compound of claim 2 wherein t and v are 0 and q is 2.
Claim 15
Dependent Claim
11 words
The compound of claim 2 wherein Z is O or N.
Claim 16
Dependent Claim
11 words
The compound of claim 2 wherein R C is asteroid molecule.
Claim 17
Dependent Claim
23 words
A compound of claim 14 wherein the steroid molecule is cholic acid, deoxycholic acid, dehydrocholic acid, cortisone, digoxigenin, testosterone, cholesterol or 3-trimethylaminomethylhydrazido cortisone.
Claim 18
Dependent Claim
13 words
The compound of claim 2 wherein R C is a water soluble vitamin.
Claim 19
Dependent Claim
31 words
The compound of claim 16 wherein the water soluble vitamin is thiamine, riboflavin, nicotinic acid, pyridoxal phosphate, pyridoxine, pyridoxamine, deoxypyridoxine, pantothenic acid, biotin, folic acid, 5'-deoxyadenosylcobalamin, inositol, choline or ascorbic acid.
Claim 20
Dependent Claim
13 words
The compound of claim 2 wherein R C is a lipid soluble vitamin.
Claim 21
Dependent Claim
26 words
The compound of claim 18 wherein the lipid soluble vitamin is a retinal, a retinol, retinoic acid, β-carotene, vitamin D, cholecalciferol, a tocopherol, or a phytol.
Claim 22
Dependent Claim
11 words
The compound of claim 2 wherein R C is a protein.
Claim 23
Dependent Claim
18 words
The compound of claim 20 wherein the protein is a phosphodiesterase, a peroxidase, a phosphatase or a nuclease.
Claim 24
Dependent Claim
12 words
The compound of claim 2 wherein R C is a reporter molecule.
Claim 25
Dependent Claim
18 words
The compound of claim 22 wherein the reporter molecule is a chromaphore, a fluorophore or a radiolabel-containing moiety.
Claim 26
Dependent Claim
15 words
The compound of claim 23 wherein the fluorophore is fluorescein, chrysine, anthracene, perylene, pyrene, rhodamine.
Claim 27
Dependent Claim
31 words
The compound of claim 2 wherein X is F, O-alkyl having from one to six carbons, O-alkoxyalkyl having from 2 to 6 carbons, or O-alkylamino having from one to six carbons.
Claim 28
Dependent Claim
12 words
The compound of claim 2 wherein R D is H or OH.
Claim 29
Dependent Claim
119 words
The compound having the structure: ##STR15## wherein: R C is O-alkyl, O-alkenyl, O-alkynyl, a polyamine, a polyether, a steroid molecule, a reporter molecule, an aromatic lipophilic molecule, a non-aromatic lipophilic molecule, a reporter enzyme, a peptide, a protein, a water soluble vitamin, a lipid soluble vitamin, a carbohydrate, a terpene molecule, a phospholipid, an intercalator, a cell receptor binding molecule, a crosslinking agent, or a porphyrin; B x is a nucleobase; X is H, OH, O-alkyl, O-alkoxyalkyl, O-alkylamino, or F; Q is O, S, CH 2 , CHF or CF 2 ; and R D is H, hydroxyl, an activated phosphorous group, a nucleoside, an activated nucleotide, a nucleotide, an oligonucleotide, an oligonucleoside or a protected protected derivative thereof.
Claim 30
Dependent Claim
119 words
The compound having the structure: ##STR15## wherein: R C is O-alkyl, O-alkenyl, O-alkynyl, a polyamine, a polyether, a steroid molecule, a reporter molecule, an aromatic lipophilic molecule, a non-aromatic lipophilic molecule, a reporter enzyme, a peptide, a protein, a water soluble vitamin, a lipid soluble vitamin, a carbohydrate, a terpene molecule, a phospholipid, an intercalator, a cell receptor binding molecule, a crosslinking agent, or a porphyrin; B x is a nucleobase; X is H, OH, O-alkyl, O-alkoxyalkyl, O-alkylamino, or F; Q is O, S, CH 2 , CHF or CF 2 ; and R D is H, hydroxyl, an activated phosphorous group, a nucleoside, an activated nucleotide, a nucleotide, an oligonucleotide, an oligonucleoside or a protected protected derivative thereof.
Claim 31
Dependent Claim
18 words
The compound of claim 27 wherein R C is a polyether, a polyamine or a non-aromatic lipophilic molecule.
Claim 32
Dependent Claim
64 words
The compound having the structure: ##STR16## wherein: J is a leaving group; B x is a nucleobase; X is H, OH, O-alkyl, O-alkoxylalkyl, O-alkylamino, or F; Q is O, S, CH 2 , CHF or CF 2 ; and R D is H, hydroxyl, an activated phosphorous group, a nucleoside, an activated nucleotide, a nucleotide, an oligonucleotide, an oligonucleoside or a protected derivative thereof.
Claim 33
Dependent Claim
64 words
The compound having the structure: ##STR16## wherein: J is a leaving group; B x is a nucleobase; X is H, OH, O-alkyl, O-alkoxylalkyl, O-alkylamino, or F; Q is O, S, CH 2 , CHF or CF 2 ; and R D is H, hydroxyl, an activated phosphorous group, a nucleoside, an activated nucleotide, a nucleotide, an oligonucleotide, an oligonucleoside or a protected derivative thereof.
Claim 34
Dependent Claim
25 words
The compound of claim 29 wherein J is OH, SH, NH 2 , trifluoromethylsulfonyl, methylsulfonyl, halogen, O-trichloroacetimidate, acyloxy, dialkyl phosphite, 2,4,6-trichlorophenyl, p-toluenesulfonyl, 4-dimethylaminoazobenzenesulfonyl or 5-dimethylaminonaphthalenesulfonyl.
References Cited (Backward Citations)
US3687808A
Cited
US5262536A
Cited
US4908453A
Cited
US5391723A
Cited
US4958013A
Cited
US5223618A
Cited
WO1993007883A1
Cited
WO1993018052A1
Cited
WO1994008051A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-03-03 | 2000-09-02 | 2001-03-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-03-03 | 2004-09-02 | 2005-03-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-03-03 | 2008-09-02 | 2009-03-04 | $7700.00 | Window Closed / Lapsed |